TY  - GEN
AU  - Kazi,Dhruv S
AU  - Moran,Andrew E
AU  - Bibbins-Domingo,Kirsten
TI  - Cost-effectiveness of PCSK9 Inhibitor Therapy-Reply
SN  - 1538-3598
PY  - 2016///1213
KW  - Cost-Benefit Analysis
KW  - Humans
KW  - Proprotein Convertases
KW  - Serine Endopeptidases
N1  - Publication Type: Letter; Comment
UR  - https://doi.org/10.1001/jama.2016.16292
ER  -